A Medical Research Council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: Cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy

Cancer

Volumn 89, Issue 6, 2000, Pages 1359-1370

  Mead, Graham M ^a   Bleehen, Norman M ^b   Gregor, Anna ^c   Bullimore, Jill ^d   Murrell, D Shirley ^e   Rampling, Roy P ^f   Roberts, J Trevor ^g   Glaser, Mark G ^h   Lantos, Peter ⁱ   Ironside, James W ^c   Moss, Timothy H ^j   Brada, Michael ^k   Whaley, Jill B ^l   Stenning, Sally P ^l  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

^b ST JOHN S COLLEGE   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d Bristol Oncology Center EORTC   (United Kingdom)

^e ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^f WESTERN INFIRMARY   (United Kingdom)

^g Northern Centre for Cancer Treatment   (United Kingdom)

^h CHARING CROSS HOSPITAL   (United Kingdom)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j FRENCHAY HOSPITAL   (United Kingdom)

^k ROYAL MARSDEN HOSPITAL   (United Kingdom)

^l MEDICAL RESEARCH COUNCIL   (United Kingdom)

more..

Author keywords

Chemotherapy; Primary cerebral lymphoma; Radiotherapy; Randomized trial

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; HYDROCORTISONE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; BLOOD BRAIN BARRIER; BLOOD TOXICITY; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DRUG PENETRATION; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NEUROLOGIC EXAMINATION; NEUROPATHY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CRANIAL IRRADIATION; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDNISONE; SURVIVAL ANALYSIS; VINCRISTINE;

EID: 0034666370     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9     Document Type: Article

References (28)

1. Increasing incidence of primary brain lymphoma in the US
2. Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature
3. Management of primary cerebral lymphoma with initial chemotherapy: Preliminary results and comparison with patients treated with radiotherapy alone
4. Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315
5. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: Prolonged survival and preservation of cognitive function
6. Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma - A pilot study of the BOMES protocol
7. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma
8. High-dose methotrexate for non-AIDS primary central nervous system lymphoma
9. Combined modality therapy for primary CNS lymphoma
10. Preirradiation methotrexate chemotherapy of primary nervous system lymphoma: Long-term outcome
11. The C5R Protocol: A regimen of high-dose chemotherapy and radiotherapy in primary cerebral non-Hodgkin's lymphoma of patients with no known cause of immunosuppression
12. Primary central nervous system non-Hodgkin's lymphoma: Survival advantages with combined initial therapy?
13. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy
14. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: Initial report of Radiation Therapy Oncology Group protocol 88-06
15. Improved survival rate in primary intracranial lymphoma treated by high-dose radiation and systemic vincristine-doxorubicin-cyclophosphamide-prednisolone chemotherapy
16. Hydroxydaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma
17. Short intensive primary chemotherapy for sporadic primary CNS lymphoma (PCL)
18. MACOP-B chemotherapy for the treatment of diffuse large cell lymphoma
19. A study of the effect of misonidazole in conjunction with radiotherapy for the treatment of grades 3 and 4 astrocytomas
20. Primary central nervous system lymphoma
21. Primary central nervous system lymphoma
22. The clinical spectrum of ocular lymphoma
23. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate grade and immunoblastic lymphoma
24. Primary central nervous system lymphoma; age and performance status are more important than treatment modality
25. Long-term survival in primary CNS lymphoma
26. High-dose methotrexate for the treatment of primary cerebral lymphomas: Analysis of survival and late neurologic toxicity in a retrospective series
27. Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma
28. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system: Preliminary data